In the midst of everything that is going on with COVID-19 it is easy to
see how important non coronavirus stuff can get overlooked. But we still
need to keep our eyes open. After a 3 year process involving many
meetings, stakeholder comments, high levels of oversight and fantastic
technical support, the National Institute of Health and Care Excellence
in the UK (NICE) released their updated guidelines on the diagnosis and
management of venous thromboembolic (VTE) disease.
Acute DVT, symptomatic chronic DVTs and Post Thrombotic Syndrome… it’s time to find out more.
Post thrombotic syndrome (PTS) is a common, but often underappreciated complication of deep vein thrombosis (DVT).
Venous thromboembolism (VTE) is the term used to describe a blood
clot in the venous system of the body. Veins carry blood back toward
the heart after the blood has been pumped to different parts of the body
and the oxygen used. When a blood clot obstructs a vein, the blockage
slows or can even stop blood flow. Whilst not the case for everyone,
when veins become blocked, they can cause painful and difficult to
manage symptoms. In particular the larger veins in the pelvis, the iliac
veins, are prone to this problem.
Thrombosis UK’s concern following the publication of the 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Author: Nicola McQuaid Peter Davies Tamara Everington
Posted In:
Tags:
The 2018 updated National Institute for Health and Care Excellence (NICE) guidance on venous thromboembolism (VTE) (NICE 2018)includes significant changes and extensions to the 2010 guidance on VTE risk assessment and thromboprophylaxis for hospital patients (NICE 2010).
Author: Will Lester, Keith Gomez, Susie Shapiro, Keval Dabhi, Mike Laffan
Posted In:
Tags:
We are writing to express our collective concern about the recommendation in the National Institute for Health and Care Excellence (NICE) guideline [NG89].
Author: Gerard Stansby, Ian Donald, Peter Barry, Dalia Dawoud, Carlos Sharpin
Posted In:
Tags:
Response: NICE NG89 recommendations for extended pharmacological thromboprophylaxis – is it justified and is it cost effective: a rebuttal from the British Society for Haematology – response to Lester et al
Could a simple blood test catch cancer before symptoms appear? Nicola Davis goes beyond the hype and investigates the future of blood diagnostics and cancer.
While there are already some NICE guidelines for psychiatry, which point at the NICE VTE prophylaxis tool, the tool itself is often irrelevant to psychiatry. Patients often have no co-morbid medical illness, and the majority of them are walking around the ward, and off the ward, just like they would at home. Most of my patients do not need VTE prophylaxis.
